These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
514 related articles for article (PubMed ID: 31215039)
21. Antitumor efficiency of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer. Wang Z; Zeng X; Ma Y; Liu J; Tang X; Gao Y; Liu K; Zhang J; Ming P; Huang L; Mei L J Biomed Nanotechnol; 2014 Aug; 10(8):1509-19. PubMed ID: 25016651 [TBL] [Abstract][Full Text] [Related]
22. pH-sensitive docetaxel-loaded D-α-tocopheryl polyethylene glycol succinate-poly(β-amino ester) copolymer nanoparticles for overcoming multidrug resistance. Zhao S; Tan S; Guo Y; Huang J; Chu M; Liu H; Zhang Z Biomacromolecules; 2013 Aug; 14(8):2636-46. PubMed ID: 23815156 [TBL] [Abstract][Full Text] [Related]
23. Polymeric mixed micelles for delivery of curcumin to multidrug resistant ovarian cancer. Saxena V; Hussain MD J Biomed Nanotechnol; 2013 Jul; 9(7):1146-54. PubMed ID: 23909128 [TBL] [Abstract][Full Text] [Related]
24. Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance. Lei M; Ma G; Sha S; Wang X; Feng H; Zhu Y; Du X Drug Deliv; 2019 Dec; 26(1):262-272. PubMed ID: 30856352 [TBL] [Abstract][Full Text] [Related]
25. D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells. Bao Y; Guo Y; Zhuang X; Li D; Cheng B; Tan S; Zhang Z Mol Pharm; 2014 Sep; 11(9):3196-209. PubMed ID: 25102234 [TBL] [Abstract][Full Text] [Related]
26. Formulation of Docetaxel by folic acid-conjugated d-α-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS(2k)) micelles for targeted and synergistic chemotherapy. Mi Y; Liu Y; Feng SS Biomaterials; 2011 Jun; 32(16):4058-66. PubMed ID: 21396707 [TBL] [Abstract][Full Text] [Related]
27. Development of liposomal pemetrexed for enhanced therapy against multidrug resistance mediated by ABCC5 in breast cancer. Bai F; Yin Y; Chen T; Chen J; Ge M; Lu Y; Xie F; Zhang J; Wu K; Liu Y Int J Nanomedicine; 2018; 13():1327-1339. PubMed ID: 29563790 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of TPGS-modified thermo-sensitive Pluronic PF127 hydrogel as a potential carrier to reverse the resistance of P-gp-overexpressing SMMC-7721 cell lines. Gao L; Wang X; Ma J; Hao D; Wei P; Zhou L; Liu G Colloids Surf B Biointerfaces; 2016 Apr; 140():307-316. PubMed ID: 26764117 [TBL] [Abstract][Full Text] [Related]
29. Doxorubicin Encapsulated in TPGS-Modified 2D-Nanodisks Overcomes Multidrug Resistance. Jiang T; Zhang C; Sun W; Cao X; Choi G; Choy JH; Shi X; Guo R Chemistry; 2020 Feb; 26(11):2470-2477. PubMed ID: 31912555 [TBL] [Abstract][Full Text] [Related]
30. Nanoformulation of D-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) diblock copolymer for breast cancer therapy. Huang L; Chen H; Zheng Y; Song X; Liu R; Liu K; Zeng X; Mei L Integr Biol (Camb); 2011 Oct; 3(10):993-1002. PubMed ID: 21938302 [TBL] [Abstract][Full Text] [Related]
31. Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance. Guo Y; Chu M; Tan S; Zhao S; Liu H; Otieno BO; Yang X; Xu C; Zhang Z Mol Pharm; 2014 Jan; 11(1):59-70. PubMed ID: 24229050 [TBL] [Abstract][Full Text] [Related]
32. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance. Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418 [TBL] [Abstract][Full Text] [Related]
33. Gambogic acid-loaded pH-sensitive mixed micelles for overcoming breast cancer resistance. Wang S; Yang Y; Wang Y; Chen M Int J Pharm; 2015 Nov; 495(2):840-8. PubMed ID: 26407923 [TBL] [Abstract][Full Text] [Related]
34. Induction of Mitochondrial Cell Death and Reversal of Anticancer Drug Resistance via Nanocarriers Composed of a Triphenylphosphonium Derivative of Tocopheryl Polyethylene Glycol Succinate. Singh Y; Viswanadham KKDR; Pawar VK; Meher J; Jajoriya AK; Omer A; Jaiswal S; Dewangan J; Bora HK; Singh P; Rath SK; Lal J; Mishra DP; Chourasia MK Mol Pharm; 2019 Sep; 16(9):3744-3759. PubMed ID: 31441308 [TBL] [Abstract][Full Text] [Related]
35. Formulation, antileukemia mechanism, pharmacokinetics, and biodistribution of a novel liposomal emodin. Wang T; Yin X; Lu Y; Shan W; Xiong S Int J Nanomedicine; 2012; 7():2325-37. PubMed ID: 22661889 [TBL] [Abstract][Full Text] [Related]
36. A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery. Bao Y; Yin M; Hu X; Zhuang X; Sun Y; Guo Y; Tan S; Zhang Z J Control Release; 2016 Aug; 235():182-194. PubMed ID: 27264552 [TBL] [Abstract][Full Text] [Related]
37. Bufalin-loaded vitamin E succinate-grafted-chitosan oligosaccharide/RGD conjugated TPGS mixed micelles demonstrated improved antitumor activity against drug-resistant colon cancer. Yuan Z; Yuan Y; Han L; Qiu Y; Huang X; Gao F; Fan G; Zhang Y; Tang X; He X; Xu K; Yin P Int J Nanomedicine; 2018; 13():7533-7548. PubMed ID: 30532537 [TBL] [Abstract][Full Text] [Related]
38. Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin. Qiu L; Qiao M; Chen Q; Tian C; Long M; Wang M; Li Z; Hu W; Li G; Cheng L; Cheng L; Hu H; Zhao X; Chen D Biomaterials; 2014 Dec; 35(37):9877-9887. PubMed ID: 25201738 [TBL] [Abstract][Full Text] [Related]
39. Chemosensitizing micelles self-assembled from amphiphilic TPGS-indomethacin twin drug for significantly synergetic multidrug resistance reversal. Chen R; Wang Z; Wu S; Kuang X; Wang X; Yan G; Tang R J Biomater Appl; 2021 Mar; 35(8):994-1004. PubMed ID: 33283586 [TBL] [Abstract][Full Text] [Related]
40. Co-delivery of docetaxel and chloroquine via PEO-PPO-PCL/TPGS micelles for overcoming multidrug resistance. Shi C; Zhang Z; Shi J; Wang F; Luan Y Int J Pharm; 2015 Nov; 495(2):932-9. PubMed ID: 26456262 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]